Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Proposed is a method for producing an aqueous solution, which has a thickening property, of an N-vinyl carboxylic acid amide copolymer. This method for producing an aqueous solution of an N-vinyl carboxylic acid amide copolymer is characterized in that a liquid containing at least a non-hydrophilic monomer (B), which is at least one selected from acrylonitrile and methyl acrylate, and a liquid containing at least a polymerization initiator (D) are added dropwise to an aqueous solution of an N-vinyl carboxylic acid amide monomer (A), and polymerization is performed.

Proposed is a method for producing an aqueous solution, which has a thickening property, of an N-vinyl carboxylic acid amide copolymer. This method for producing an aqueous solution of an N-vinyl carboxylic acid amide copolymer is characterized in that a liquid containing at least a non-hydrophilic monomer (B), which is at least one selected from acrylonitrile and methyl acrylate, and a liquid containing at least a polymerization initiator (D) are added dropwise to an aqueous solution of an N-vinyl carboxylic acid amide monomer (A), and polymerization is performed.

Proposed is a method for producing an aqueous solution, which has a thickening property, of an N-vinyl carboxylic acid amide copolymer. This method for producing an aqueous solution of an N-vinyl carboxylic acid amide copolymer is characterized in that a liquid containing at least a non-hydrophilic monomer (B), which is at least one selected from acrylonitrile and methyl acrylate, and a liquid containing at least a polymerization initiator (D) are added dropwise to an aqueous solution of an N-vinyl carboxylic acid amide monomer (A), and polymerization is performed.

Polycationic polymeric antimicrobial surfactant and polymeric biocompatible antimicrobial surfactant compositions are useful in dispersing various compounds in a carrier liquid. The polycationic polymeric antimicrobial surfactant and polymeric biocompatible antimicrobial surfactant compositions employ polymers having both hydrophilic domains and hydrophobic domains so that the compositions can disperse particles such as polymer particles or droplets in a continuous phase as well as provide stable dispersions that have not been provided before. The antimicrobial properties of the compositions provide much-needed capabilities of fighting infectious agents such as bacteria and viruses in a wide spectrum of products such as paint, adhesives, and coatings. Methods of using these compositions as well as methods of making products using the compositions are disclosed.

Polycationic polymeric antimicrobial surfactant and polymeric biocompatible antimicrobial surfactant compositions are useful in dispersing various compounds in a carrier liquid. The polycationic polymeric antimicrobial surfactant and polymeric biocompatible antimicrobial surfactant compositions employ polymers having both hydrophilic domains and hydrophobic domains so that the compositions can disperse particles such as polymer particles or droplets in a continuous phase as well as provide stable dispersions that have not been provided before. The antimicrobial properties of the compositions provide much-needed capabilities of fighting infectious agents such as bacteria and viruses in a wide spectrum of products such as paint, adhesives, and coatings. Methods of using these compositions as well as methods of making products using the compositions are disclosed.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

The present invention is directed to an addition polymer comprising an addition polymer backbone; at least one moiety comprising a sulfonic acid group; and at least one carbamate functional group. The present invention is also directed towards methods of making the addition polymer, aqueous resinous dispersions comprising the addition polymer, methods of coating a substrate and coated substrates.